Salon
Jun 30, 2024 - 22 min
News and insights read out for you.
10,000+ audio articles. 30+ world-leading publications.
All in 1 subscription.
Who will benefit from psychedelic medicine?
33 mins | Sep 30, 2020
The troubles of accessibility are already present. MDMA-assisted psychotherapy is a turning point in the mainstreaming of psychedelics. These substances are being touted as a game-changing intervention for mental health. Whitney Joiner investigates the promise that this treatment could be accessible to all.
If you want all the articles from The Washington Post click here to subscribe.
